AlanFSchatzbergMD
Psychiatry • Palo Alto, CADirector, Stanford Mood Disorders Center. Professor, Department of Psychiatry and Behavioral Sciences Stanford University Medical Center.
Dr. Schatzberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 Quarry Rd
Palo Alto, CA 94304Phone+1 650-498-9111Fax+1 650-498-5294- Is this information wrong?
Education & Training
Brigham and Women's Hospital/Harvard Medical SchoolResidency, Psychiatry, 1969 - 1972
Lenox Hill Hospital-Northwell HealthInternship, Transitional Year, 1968 - 1969
New York University School of MedicineClass of 1968
Certifications & Licensure
MA State Medical License 1969 - 2025
CA State Medical License 1974 - 2024- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Women's Health Castle Connolly, 2008
- Elected Member Institute of Medicine, 2003
- Join now to see all
Clinical Trials
- Age-Related Changes in Stress Hormone Regulation Start of enrollment: 2000 Dec 01
- Clinical and Biological Characteristics of Psychotic Depression Start of enrollment: 2005 Aug 01
- Genetics of Symptomatology and Treatment Response in Psychotic Major Depression Start of enrollment: 2003 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Proteomic profiles of cytokines and chemokines in moderate to severe depression: Implications for comorbidities and biomarker discovery.Watson, K., Keller, J., Spiro, C., Satz, I., Goncalves, S., Pankow, H., Kosti, I., Lehallier, B., Sequeira, A., Bunney, W., Rasgon, N., Schatzberg, A.> ;Brain, Behavior, & Immunity - Health. 2024 Mar 1
- Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials.Vreijling, S., Chin Fatt, C., Williams, L., Schatzberg, A., Usherwood, T., Nemeroff, C., Rush, A., Uher, R., Aitchison, K., Köhler-Forsberg, O., Rietschel, M., Trivedi...> ;The British Journal of Psychiatry. 2024 Mar 1
- 7 citationsRandomized trial of ketamine masked by surgical anesthesia in patients with depression.Smith, A., Flohr, J., Okada, R., Nyongesa, C., Cianfichi, L., Lii, T., Hack, L., Schatzberg, A., Heifets, B.> ;Nature Mental Health. 2023 Nov 1
- Join now to see all
Journal Articles
- Splice-Break: Exploiting an RNA-Seq Splice Junction Algorithm to Discover Mitochondrial DNA Deletion Breakpoints and Analyses of Psychiatric DisordersFrancis S Lee, Alan F Schatzberg, Jack D Barchas, Virginia Kimonis, Elizabeth C Chao, Nucleic Acids Research
- Double-Blind, Placebo-Controlled, Dose-Ranging Trial of Intravenous Ketamine as Adjunctive Therapy in Treatment-Resistant Depression (TRD)Sanjay J Mathew, Madhukar H Trivedi, Lee C Chang, Dan V Iosifescu, Manish K Jha, Maurizio Fava, Marlene P Freeman, Cristina Cusin, James Murrough, George I Papakostas,..., Nature
- American Psychiatric Association PublishingAlan Schatzberg, MD, National Institutes of Health
Press Mentions
Magnus Medical Receives FDA Clearance for the SAINT Neuromodulation System for Non-Invasive, Individualized and Precise Treatment of Severe DepressionSeptember 6th, 2022- A Virtual Conversation with with Dr. Amit Etkin, Founder and CEO of Alto NeuroscienceMarch 9th, 2022
- Biomarker in Platelets May Pinpoint Depression, Treatment ResponseFebruary 9th, 2022
- Join now to see all
Hospital Affiliations
Stanford Health CarePalo Alto, California
VA Palo Alto Heath CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
